# Spitfire Pharma, Inc. — Form D

Spitfire Pharma, Inc. of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2013-01-11. The offering totals $9.5M, of which $500K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2013-01-11
- Form: D
- Accession: 0001566043-13-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $9.5M
- Amount sold: $500K
- Remaining: $9.0M
- Investors: 1
- Date of first sale: 2012-12-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-190044

## Issuer

- Name: Spitfire Pharma, Inc.
- CIK: 0001566043
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 400 OYSTER POINT BOULEVARD SUITE 202, SOUTH SAN FRANCISCO, CA, 94080
- Phone: 415-689-5709

## Officers, directors & promoters (2)

| Name | Role | Location |
| --- | --- | --- |
| Brett Cummings | Director | San Francisco, CA |
| Edward Schnipper | Executive Officer | Grand Prairie, TX |

## More

- [CIK 1566043 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1566043&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001566043-13-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.